Pharmacovigilance for biologicals in The Netherlands

Posted 12/02/2016

Escher is an independent regulatory research platform run by Netherlands-based research enabler TI Pharma. The group recently published a paper in the journa...

more
Launch of partnership for biosimilars education... Biosimilars/General | Posted 12/02/2016
Consumer choice between generic and brand-name... Generics/Research | Posted 12/02/2016
Kyowa to market Sandoz’s rituximab biosimilar i... Biosimilars/News | Posted 12/02/2016
Mylan launches generic seizure drug in US Generics/News | Posted 12/02/2016
Impact of generics on European budgets Reports | Posted 12/02/2016
Adalimumab biosimilar meets primary endpoint in... Biosimilars/Research | Posted 12/02/2016
Biosimilars in UK gain NICE recommendation Policies & Legislation | Posted 05/02/2016
Biosimilar etanercept offered at 47% discount i... Biosimilars/General | Posted 05/02/2016
Generics applications under review by EMA – Dec... Generics/General | Posted 05/02/2016
Positive phase III results for cetuximab and in... Biosimilars/Research | Posted 05/02/2016
Celgene settles Revlimid patent litigation with... Generics/News | Posted 05/02/2016
Lack of health insurance limits access to biolo... Biosimilars/Research | Posted 05/02/2016
Australian approval for infertility biosimilar... Biosimilars/News | Posted 05/02/2016
12th EGA Legal Affairs Conference Conferences | Posted 05/02/2016
EBG Biosimilars Conference 2016 Conferences | Posted 05/02/2016
Prescribing similar biotherapeutic products in... Biosimilars/Research | Posted 29/01/2016
Biosimilars applications under review by EMA –... Biosimilars/General | Posted 29/01/2016
Further capping of generics in Japan Policies & Legislation | Posted 29/01/2016
Pharmacists’ attitudes towards domestic generic... Generics/Research | Posted 29/01/2016
FDA finalizes guidance for biosimilars meetings Guidelines | Posted 29/01/2016
Partnerships driving similar biologics developm... Biosimilars/Research | Posted 29/01/2016
FDA approval for generic antibiotic and arrhyth... Generics/News | Posted 29/01/2016
Filgrastim follow-on biological approved in Brazil Biosimilars/News | Posted 29/01/2016
What happened in biosimilars during 2015 Biosimilars/General | Posted 22/01/2016
Paediatric use of low-cost generic programs in... Generics/Research | Posted 22/01/2016
Roche and India's Glenmark reach truce over gen... Generics/News | Posted 22/01/2016
Generics market share in Europe Reports | Posted 22/01/2016
Domestic biologicals cost less in India Biosimilars/Research | Posted 22/01/2016
Eisai acquires Chinese generics maker Pharma News | Posted 22/01/2016
Bevacizumab non-originator biological approved... Biosimilars/News | Posted 22/01/2016
6th Annual OTC Pharma Asia 2016 Conferences | Posted 22/01/2016
Pharmaceutical Congress China 2016 Conferences | Posted 22/01/2016
Biopharma Development & Production 2016 Conferences | Posted 22/01/2016
Top 10 most read GaBI Online articles in 2015 Pharma News | Posted 15/01/2016
Barriers to biologicals competition Biosimilars/Research | Posted 15/01/2016
Physicians’ and pharmacists’ perspectives on ge... Generics/Research | Posted 15/01/2016
EMA accepts application for etanercept biosimilar Biosimilars/News | Posted 15/01/2016
Michigan introduces new biosimilars substitutio... Policies & Legislation | Posted 15/01/2016
Doctors in the US should remember to prescribe... Biosimilars/Research | Posted 15/01/2016
Low costs and less stringent regulatory require... Biosimilars/Research | Posted 15/01/2016
Use of generics in cardiovascular diseases Generics/Research | Posted 08/01/2016
FDA approves first follow-on insulin glargine t... Biosimilars/News | Posted 08/01/2016
Inflectra PBS listing expected to deliver savin... Biosimilars/General | Posted 08/01/2016
Pegfilgrastim biosimilar as safe and effective... Biosimilars/Research | Posted 08/01/2016
more